The authors regret that in the article as originally published, the author Giuseppe Tarantini’s name was misspelled. His name has been corrected above. The authors would like to apologise for…
Summary The cardioprotective effect of therapeutic hypothermia (32–34 °C) has been well demonstrated in animal models of acute myocardial infarction. Beyond infarct size reduction, this protection was associated with prevention…
Summary Atherosclerosis is an inflammatory disease within the arterial wall that is responsible for several important adverse vascular events, including coronary artery disease, myocardial infraction, stroke and peripheral artery disease….
Summary Background Despite numerous studies in recent years, the best anticoagulant option for primary percutaneous coronary intervention (PCI) remains a matter of debate. Aims To compare in-hospital outcomes after prehospital…
Summary Background Left atrial appendage (LAA) closure using the WATCHMAN™ device (WM) may be considered in patients with non-valvular atrial fibrillation (AF) and a high-risk of stroke who are ineligible…
Summary Background Catheter ablation (CA) of persistent atrial fibrillation (AF) is challenging, and reported results are capable of improvement. A better patient selection for the procedure could enhance its success…
Summary Background The prevalence and incidence of heart failure (HF) in elderly patients are increasing worldwide. Management of HF with reduced ejection fraction (HF-REF) in patients aged 80 years or…
Summary Background Percutaneous left atrial appendage (LAA) closure has emerged as an alternative therapeutic option for the prevention of embolic stroke in high-risk patients with non-valvular atrial fibrillation. The presence…
Non-valvular new onset supraventricular arrhythmia (SVA; atrial fibrillation, atrial flutter, atrial tachysystolia) is the most frequent rhythm disorder in surgical and non-surgical intensive care units (ICUs), occurring in 4.5% to…
